Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pcbi.1010330
PubMed Identifier: 35849631
Publication URI: http://europepmc.org/abstract/MED/35849631
Type: Journal Article/Review
Volume: 18
Parent Publication: PLoS computational biology
Issue: 7
ISSN: 1553-734X